Safety of “hot” and “cold” site admissions within a high‐volume urology department in the United Kingdom at the peak of the COVID‐19 pandemic
BJUI Compass2021Vol. 2(2), pp. 97–104
Citations Over Time
Luke Stroman, Beth Russell, Pinky Kotecha, Anastasia Kantartzi, Luís Ribeiro, Bethany Jackson, Vugar Ismaylov, Adeoye Oluwakanyinsola Debo‐Aina, Findlay MacAskill, Francesca Kum, Meghana Kulkarni, Raveen Sandher, Anna Walsh, Ella Doerge, K. Guest, Yamini Kailash, Nick Simson, Cassandra McDonald, Elsie Mensah, Li June Tay, Ramandeep Chalokia, Sharon Clovis, Elizabeth Eversden, Jane Cossins, Jonah Rusere, Grace Zisengwe, Louisa Fleure, Leslie Cooper, Kathryn Chatterton, Amelia Barber, Catherine Roberts, Thomasia Azavedo, Jeffrey Ritualo, Harold Omana, Liza Mills, L Studd, Oussama El Hage, Rajesh Nair, Sachin Malde, Arun Sahai, Archana Fernando, Claire Taylor, Ben Challacombe, Ramesh Thurairaja, Rick Popert, Jonathon Olsburgh, P. Cathcart, Christian Brown, Marios Hadjipavlou, Ella Di Benedetto, Matthew Bultitude, Jonathon Glass, Tet Yap, Rhana Zakri, Majed Shabbir, Susan Willis, Kay Thomas, Tim O’Brien, Muhammad Shamim Khan, Prokar Dasgupta
Abstract
Continuation of urological procedures using "hot" and "cold" sites throughout the COVID-19 pandemic was safe practice, although the risk of COVID-19 remained and is underlined by a postoperative mortality.
Related Papers
- → Chilblain‐like lesions after BNT162b2 mRNA COVID‐19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS‐CoV‐2(2021)26 cited
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → ОПЫТ ИССЛЕДОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ К ВИРУСУ SARS-CoV-2 НАСЕЛЕНИЯ ИРКУТСКОЙ ОБЛАСТИ В ПЕРИОД ВСПЫШКИ COVID-19(2020)2 cited
- → Особенности сахароснижающей фармакотерапии у пациентов с SARS-CoV-2 (COVID-19)(2021)